Our Services
Medical Information
Helpful Resources
Published on: 4/4/2026
Farxiga is not recommended during pregnancy, including for gestational diabetes, because SGLT2 inhibitors may affect fetal kidney development and carry maternal risks such as urinary infections, dehydration, low blood pressure, and rare ketoacidosis.
Standard care centers on diet, exercise, blood sugar monitoring, and usually insulin when medication is needed, with metformin sometimes considered; there are several factors to consider about alternatives, accidental early exposure, and urgent warning signs, so see the complete guidance below to understand more and choose next steps with your clinician.
Gestational diabetes is a type of diabetes that develops during pregnancy. It affects how your body uses blood sugar (glucose) and can impact both mother and baby if not properly managed. Many people diagnosed with gestational diabetes wonder about medication options—including drugs like Farxiga.
If you are pregnant or planning to become pregnant, it's important to understand what Farxiga is, how it works, and why it is not typically recommended during pregnancy. This guide explains the facts clearly and calmly, so you can make informed decisions with your healthcare provider.
Gestational diabetes mellitus (GDM) occurs when pregnancy hormones make it harder for your body to use insulin effectively. As a result, blood sugar levels rise.
It usually develops between 24 and 28 weeks of pregnancy, though it can occur earlier in some women.
Uncontrolled gestational diabetes can increase the risk of:
The good news is that with proper management, most women have healthy pregnancies and healthy babies.
Farxiga (generic name: dapagliflozin) is a prescription medication used to treat:
It belongs to a class of medications called SGLT2 inhibitors. These drugs lower blood sugar by helping the kidneys remove excess glucose from the body through urine.
No. Farxiga is not approved or recommended for use during pregnancy, including for gestational diabetes.
There are important safety concerns:
Because of this, major medical guidelines recommend avoiding Farxiga during pregnancy.
If you are taking Farxiga and become pregnant, contact your doctor promptly to discuss safer alternatives.
Treatment typically focuses on:
For many women, this is enough.
If lifestyle changes are not enough, insulin is considered the safest medication during pregnancy because it does not cross the placenta.
Some providers may prescribe certain oral diabetes medications like metformin, though insulin remains the gold standard when medication is needed.
Farxiga is not part of recommended treatment options for gestational diabetes.
Even outside of pregnancy, understanding Farxiga side effects is important. While many people tolerate it well, there are known risks.
These occur because the medication causes more sugar to pass through the urine, creating an environment where infections can develop more easily.
Though less common, serious risks include:
Because pregnancy already changes kidney function, blood volume, and immune response, adding a medication with these potential risks is generally avoided.
Pregnancy changes your body significantly:
Since common Farxiga side effects include dehydration and urinary infections, these could pose additional risks during pregnancy.
Moreover, the potential effects on fetal kidney development make it unsuitable for pregnant patients.
If this has happened, try not to panic.
Accidental early exposure does not automatically mean there will be harm. The next steps should include:
Your healthcare provider can guide you through safe follow-up care.
If you're experiencing symptoms that may be related to blood sugar concerns, consider using a free Diabetes Mellitus symptom checker to better understand your condition and determine if you should seek medical attention. This AI-powered tool can help identify whether your symptoms align with diabetes and guide your next steps.
However, online tools should never replace medical care—especially during pregnancy.
It's normal to feel overwhelmed after a diagnosis. But here are reassuring facts:
What matters most is consistent follow-up and clear communication with your healthcare team.
Even if your blood sugar returns to normal after delivery, gestational diabetes increases your lifetime risk of developing type 2 diabetes.
Your doctor may recommend:
In non-pregnant individuals with type 2 diabetes, medications like Farxiga may become an option—but that decision should be made carefully with your physician, considering the potential Farxiga side effects and your overall health profile.
Seek medical attention promptly if you experience:
These could signal serious complications that require urgent evaluation.
Always speak to a doctor about anything that could be life-threatening or serious.
Gestational diabetes requires attention—but it is manageable. With the right support, careful monitoring, and evidence-based treatment, you can protect both your health and your baby's health.
If you have concerns about your symptoms, medication history, or blood sugar levels, speak to a doctor promptly. Early, informed care makes all the difference.
(References)
* Jara-Romero A, Monleon-Lahoz R, Pascual-Aguilar M, Lopez-Miranda J, Nacher-Carreres A, Galiano-Moreno M. Use of SGLT-2 inhibitors during pregnancy: what we know so far. Diabetes Metab Res Rev. 2023 Mar;39(3):e3630. doi: 10.1002/dmrr.3630. Epub 2022 Nov 3. PMID: 36333649.
* Vardhana SS, Dhage S, Singh A, Kalra S. SGLT2 Inhibitors in Pregnancy: A Review of Current Evidence and Clinical Implications. J Clin Med. 2021 May 21;10(11):2274. doi: 10.3390/jcm10112274. PMID: 34067338; PMCID: PMC8197793.
* Gao Z, Yang B, Yang B, Zhou Q, Chen S, Chen X, Yang M. Pharmacological Management of Gestational Diabetes Mellitus: A Narrative Review. Metabolites. 2023 Sep 8;13(9):982. doi: 10.3390/metabo13090982. PMID: 37763632; PMCID: PMC10534273.
* Lin Z, Li M, Zhang H, Huang K. Safety and Efficacy of SGLT2 Inhibitors in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Dec 27;20(1):310. doi: 10.3390/ijerph20010310. PMID: 36677469; PMCID: PMC9819615.
* Jara-Romero A, Monleón-Lahoz R, Monleón-Lahoz A, Belda-Rufat V, Galiano-Moreno M, Almenar-Arasanz M. Dapagliflozin Exposure During Pregnancy: A Review of Available Evidence and Potential Implications. Drugs Real World Outcomes. 2024 Mar;11(1):21-34. doi: 10.1007/s40801-023-00407-7. Epub 2024 Feb 5. PMID: 38317180; PMCID: PMC10842265.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.